Literature DB >> 24310985

LIM homeobox transcription factor 1B is associated with pro-fibrotic components and apoptosis in hypoxia/reoxygenation renal tubular epithelial cells.

Tian-Biao Zhou1, Hui-Ling Xu, Yuan-Han Qin, Feng-Ying Lei, Wei-Fang Huang, Gregor P C Drummen.   

Abstract

LIM homeobox transcription factor 1B (LMX1B) is a transcription factor of the LIM-homeodomain type, which plays an important role in foetal development during formation of the extremities, kidneys, eyes, and the brain. Furthermore, LMX1B has been implicated in nail-patella syndrome, which is predominantly characterized by malformation of limbs and nails, and in 30 % of patients, nephropathy, including renal fibrosis, is observed. Since no reports were available that studied the link between LMX1B expression and pro-fibrotic components and apoptosis in hypoxic renal tubular epithelial cells (RTEC), we explored if LMX1B was associated with extracellular matrix components, profibrotic factors, and apoptosis induced by hypoxia/reoxygenation (H-R). In this cell system under hypoxic conditions, when the expression of LMX1B was inhibited in H-R RTEC, the expression of transforming growth factor-βl, collagen-III, fibronectin, cleaved caspase-3, and cell apoptosis rate was increased. Consequently, overexpression of LMX1B was associated with reduced cell apoptosis, whilst downregulation of LMX1B was associated with increased cell apoptosis in H-R RTEC.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24310985     DOI: 10.1007/s10495-013-0952-1

Source DB:  PubMed          Journal:  Apoptosis        ISSN: 1360-8185            Impact factor:   4.677


  2 in total

1.  Knockdown of LMX1B Suppressed Cell Apoptosis and Inflammatory Response in IL-1β-Induced Human Osteoarthritis Chondrocytes through NF-κB and NLRP3 Signal Pathway.

Authors:  Yiping Mu; Lining Wang; Ling Fu; Qi Li
Journal:  Mediators Inflamm       Date:  2022-09-12       Impact factor: 4.529

2.  cMet agonistic antibody attenuates apoptosis in ischaemia-reperfusion-induced kidney injury.

Authors:  Jung Nam An; Lilin Li; Junghun Lee; Seung-Shin Yu; Jeonghwan Lee; Yong Chul Kim; Dong Ki Kim; Yun Kyu Oh; Chun Soo Lim; Yon Su Kim; Sunyoung Kim; Seung Hee Yang; Jung Pyo Lee
Journal:  J Cell Mol Med       Date:  2020-04-02       Impact factor: 5.310

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.